Holcmann M - Search Results

1

Ex-Vivo Skin Explant Culture Is a Model for TSLP-Mediated Skin Barrier Immunity.

Bauer T, Gubi D, Klufa J, Novoszel P, Holcmann M, Sibilia M. Bauer T, et al. Among authors: holcmann m. Life (Basel). 2021 Nov 16;11(11):1237. doi: 10.3390/life11111237. Life (Basel). 2021. PMID: 34833113 Free PMC article.

2

Identification and characterization of pDC-like cells in normal mouse skin and melanomas treated with imiquimod.

Palamara F, Meindl S, Holcmann M, Lührs P, Stingl G, Sibilia M. Palamara F, et al. Among authors: holcmann m. J Immunol. 2004 Sep 1;173(5):3051-61. doi: 10.4049/jimmunol.173.5.3051. J Immunol. 2004. PMID: 15322165

3

The epidermal growth factor receptor: from development to tumorigenesis.

Sibilia M, Kroismayr R, Lichtenberger BM, Natarajan A, Hecking M, Holcmann M. Sibilia M, et al. Among authors: holcmann m. Differentiation. 2007 Nov;75(9):770-87. doi: 10.1111/j.1432-0436.2007.00238.x. Differentiation. 2007. PMID: 17999740 Review.

4

Skin inflammation is not sufficient to break tolerance induced against a novel antigen.

Holcmann M, Stoitzner P, Drobits B, Luehrs P, Stingl G, Romani N, Maurer D, Sibilia M. Holcmann M, et al. J Immunol. 2009 Jul 15;183(2):1133-43. doi: 10.4049/jimmunol.0713351. Epub 2009 Jul 1. J Immunol. 2009. PMID: 19570825

5

TNFalpha shedding and epidermal inflammation are controlled by Jun proteins.

Guinea-Viniegra J, Zenz R, Scheuch H, Hnisz D, Holcmann M, Bakiri L, Schonthaler HB, Sibilia M, Wagner EF. Guinea-Viniegra J, et al. Among authors: holcmann m. Genes Dev. 2009 Nov 15;23(22):2663-74. doi: 10.1101/gad.543109. Genes Dev. 2009. PMID: 19933155 Free PMC article.

6

High-affinity IgE receptors on dendritic cells exacerbate Th2-dependent inflammation.

Sallmann E, Reininger B, Brandt S, Duschek N, Hoflehner E, Garner-Spitzer E, Platzer B, Dehlink E, Hammer M, Holcmann M, Oettgen HC, Wiedermann U, Sibilia M, Fiebiger E, Rot A, Maurer D. Sallmann E, et al. Among authors: holcmann m. J Immunol. 2011 Jul 1;187(1):164-71. doi: 10.4049/jimmunol.1003392. Epub 2011 May 27. J Immunol. 2011. PMID: 21622859

7

hVps37A Status affects prognosis and cetuximab sensitivity in ovarian cancer.

Wittinger M, Vanhara P, El-Gazzar A, Savarese-Brenner B, Pils D, Anees M, Grunt TW, Sibilia M, Holcmann M, Horvat R, Schemper M, Zeillinger R, Schöfer C, Dolznig H, Horak P, Krainer M. Wittinger M, et al. Among authors: holcmann m. Clin Cancer Res. 2011 Dec 15;17(24):7816-27. doi: 10.1158/1078-0432.CCR-11-0408. Epub 2011 Oct 20. Clin Cancer Res. 2011. PMID: 22016507

8

Imiquimod clears tumors in mice independent of adaptive immunity by converting pDCs into tumor-killing effector cells.

Drobits B, Holcmann M, Amberg N, Swiecki M, Grundtner R, Hammer M, Colonna M, Sibilia M. Drobits B, et al. Among authors: holcmann m. J Clin Invest. 2012 Feb;122(2):575-85. doi: 10.1172/JCI61034. Epub 2012 Jan 17. J Clin Invest. 2012. PMID: 22251703 Free PMC article.

9

How imiquimod licenses plasmacytoid dendritic cells to kill tumors.

Holcmann M, Drobits B, Sibilia M. Holcmann M, et al. Oncoimmunology. 2012 Dec 1;1(9):1661-1663. doi: 10.4161/onci.22033. Oncoimmunology. 2012. PMID: 23264929 Free PMC article.

10

Epidermal EGFR controls cutaneous host defense and prevents inflammation.

Lichtenberger BM, Gerber PA, Holcmann M, Buhren BA, Amberg N, Smolle V, Schrumpf H, Boelke E, Ansari P, Mackenzie C, Wollenberg A, Kislat A, Fischer JW, Röck K, Harder J, Schröder JM, Homey B, Sibilia M. Lichtenberger BM, et al. Among authors: holcmann m. Sci Transl Med. 2013 Aug 21;5(199):199ra111. doi: 10.1126/scitranslmed.3005886. Sci Transl Med. 2013. PMID: 23966300

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

29 results

Search Page

Filters